ZONKAYRAS

Serial Number 98302890
730

Registration Progress

Application Filed
Dec 7, 2023
Under Examination
Sep 17, 2024
Approved for Publication
Jul 23, 2024
Published for Opposition
Jul 23, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Sep 17, 2025 44 days

Trademark Image

ZONKAYRAS

Basic Information

Serial Number
98302890
Filing Date
December 7, 2023
Published for Opposition
July 23, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 4, 2025
Application
Pending
Classes
005

Rights Holder

Eli Lilly and Company

03
Address
Lilly Corporate Center
Indianapolis, IN 46285

Ownership History

Eli Lilly and Company

Original Applicant
03
Indianapolis, IN

Eli Lilly and Company

Owner at Publication
03
Indianapolis, IN

Legal Representation

Attorney
Bruce W. Longbottom

USPTO Deadlines

Next Deadline
44 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
September 17, 2025
Extension Available
Until September 17, 2025

Application History

12 events
Date Code Type Description Documents
Feb 5, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 4, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 4, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 4, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 17, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 20, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 20, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Additional Information

Translation
The wording "ZONKAYRAS" has no meaning in a foreign language.

Classification

International Classes
005